
Ionis Pharmaceuticals Inc (IONS)
US$ 33.533.94%
Price Chart
Key Statistics
Market Cap
$ 5.49B
P/E Ratio
0.00
Revenue (TTM)
$ 717.25M
Volume
1.37M
52W High
$ 52.34
52W Low
$ 23.95
Dividend Yield
0.00%
Beta
0.15
Technicals
50-Day MA
30.9518
200-Day MA
36.3792
52 Week High
52.34
52 Week Low
23.95
About IONS
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
Employees
1069
Headquarters
Carlsbad, CA
CEO
Dr. Brett P. Monia Ph.D.
Latest News
Scientists discover how solar events affect the velocity of helium pickup ions - Phys.org
16 hours ago • Google News
Solar Events Found to Accelerate Helium Pickup Ions Beyond Solar Wind Speeds - Space Daily
5 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
36.64
Percentile: 62.18
Environmental Risk Score
5.18
Percentile: 9
Social Risk Score
26.17
Percentile: 9
Governance Risk Score
13.29
Percentile: 9
Controversy Level
ESG data provided by Sustainalytics, Inc.
IONS
Category Average
N/ANone Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg